AbbVie
ABBV
#27
Rank
$337.52 B
Marketcap
$191.08
Share price
-0.70%
Change (1 day)
12.61%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Operating Margin for AbbVie (ABBV)

Operating Margin as of June 2025 (TTM): 6.31%

According to AbbVie's latest financial reports and stock price the company's current Operating Margin is 6.31%. At the end of 2024 the company had an Operating Margin of 6.60%.

Operating Margin history for AbbVie from 2011 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
20246.60%-42.67%
202311.51%-50.43%
202223.21%0.44%
202123.11%211.56%
20207.42%-70.71%
201925.33%59.63%
201815.87%-42.06%
201727.39%-10.95%
201630.75%5.79%
201529.07%144.93%
201411.87%-58.17%
201328.38%-8.9%
201231.15%48.13%
201121.03%-32%
201030.92%-26.13%
200941.86%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Pfizer
PFE
12.60% 99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
12.82% 103.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
27.75% 339.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
19.48% 208.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
23.75% 276.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
17.85% 182.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
13.32% 111.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
16.07% 154.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
20.63% 226.94%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.